Squarepoint
MXCT icon

Squarepoint’s MaxCyte MXCT Stock Holding History

Squarepoint’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,999
Closed -$50.1K – 4764
2025
Q2 		$50.1K Sell
22,999
-39,605
-63% -$95.9K ﹤0.01% 4305
2025
Q1 		$171K Buy
62,604
+27,961
+81% +$110K ﹤0.01% 4072
2024
Q4 		$144K Sell
34,643
-109,174
-76% -$413K ﹤0.01% 4585
2024
Q3 		$559K Sell
143,817
-172
-0.1% -$725 ﹤0.01% 3011
2024
Q2 		$564K Sell
143,989
-25,153
-15% -$108K ﹤0.01% 2990
2024
Q1 		$709K Buy
169,142
+57,767
+52% +$271K ﹤0.01% 2826
2023
Q4 		$523K Buy
+111,375
New +$434K ﹤0.01% 2981
2023
Q3 		– Sell
-14,173
Closed -$65.1K – 4081
2023
Q2 		$65.1K Sell
14,173
-7,114
-33% -$32.7K ﹤0.01% 3420
2023
Q1 		$105K Buy
+21,287
New +$105K ﹤0.01% 2965
2022
Q3 		– Sell
-24,000
Closed -$114K – 3267
2022
Q2 		$114K Buy
+24,000
New +$118K ﹤0.01% 2600

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint's MXCT Position: Q3 2025 in Review

Squarepoint sold out of MaxCyte (MXCT) in Q3 2025, closing a stake of 22,999 shares — an estimated $50.1K sold.

Squarepoint first reported a position in MXCT in Q2 2022 and held it in 10 quarters. The position peaked at $709K in Q1 2024. 112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

  • Squarepoint reported no remaining MaxCyte position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 22,999 MaxCyte shares in Q3 2025, an estimated $50.1K.
  • Squarepoint first reported a position in MaxCyte in Q2 2022 and held it in 10 quarters.
  • Squarepoint's MaxCyte position peaked at $709K in Q1 2024.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.